Search company, investor...

Investors Count

2

Deal Terms

1

Funding, Valuation & Revenue

2 Fundings

Viagene's latest funding round was a Acquired for on October 2, 1995.

Viagene's latest post-money valuation is from October 1995.

Sign up for a free demo to see Viagene's valuations in October 1995 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/2/1995

Acquired

$99M

0

FY undefined

1

Other Investors

$99M

0

FY undefined

0

Date

10/2/1995

Round

Acquired

Other Investors

Amount

Investors

Valuation

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

Sources

1

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Viagene Deal Terms

1 Deal Term

Viagene's deal structure is available for 1 funding round, including their Acquired from October 02, 1995.

Round

Acquired

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Viagene Investors

2 Investors

Viagene has 2 investors. Chiron invested in Viagene's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/2/1995

10/2/1995

1
Acquired

Corporation

France

Domain Associates

Subscribe to see more

Venture Capital

New Jersey

First funding

10/2/1995

Last Funding

10/2/1995

Investor

Domain Associates

Rounds

1
Acquired

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Location

France

New Jersey

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.